KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $43,000 | -8.5% | 11,500 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $47,000 | -11.3% | 11,500 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $53,000 | -35.4% | 11,500 | 0.0% | 0.01% | -36.4% |
| Q3 2017 | $82,000 | -1.2% | 11,500 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $83,000 | +3.8% | 11,500 | -11.5% | 0.01% | +10.0% |
| Q1 2017 | $80,000 | +19.4% | 13,000 | +13.0% | 0.01% | +25.0% |
| Q4 2016 | $67,000 | +26.4% | 11,500 | +15.0% | 0.01% | +14.3% |
| Q3 2016 | $53,000 | -19.7% | 10,000 | 0.0% | 0.01% | -12.5% |
| Q2 2016 | $66,000 | +40.4% | 10,000 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $47,000 | -7.8% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $51,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
| EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
| Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
| Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
| SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
| Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
| OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
| NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
| Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |